Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic LeukemiaStéphane de Botton, the European APL Group, Claude Gardin et al.|Blood|1998Cited by 338
Therapy-Related Acute Promyelocytic LeukemiaMarie Beaumont, Pierre Fenaux, Miguel Á. Sanz et al.|Journal of Clinical Oncology|2003Cited by 215
Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-<i>Trans</i>-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia GroupStéphane de Botton, Pierre Fenaux, A Fawaz et al.|Journal of Clinical Oncology|2004Cited by 135
Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 studyNorbert Vey, J Gäbert, Xavier Thomas et al.|Leukemia|2006Cited by 72
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trialStéphane de Botton, Sylvie Chevret, Valérie Coiteux et al.|Leukemia|2003Cited by 71